Abbott Laboratories (ABT) Treasury Shares (2009 - 2026)

Abbott Laboratories has disclosed Treasury Shares across 18 years of filings, most recently posting $18.0 billion for Q2 2026.

• In Q2 2026, Treasury Shares rose 8.17% year-over-year to $18.0 billion; the TTM figure through Jun 2026 stood at $18.0 billion (up 8.17% YoY), while the FY2025 annual figure was $17.2 billion, up 1.98% from the prior year.
• Treasury Shares came in at $18.0 billion for Q2 2026 at Abbott Laboratories, up from $16.9 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $267.9 million in Q2 2026 to a low of $234.5 million in Q2 2022.
• Average Treasury Shares over 5 years is $252.0 million, with a median of $252.8 million recorded in 2023.
• Year-over-year, Treasury Shares surged 39.42% in 2022 and rose 0.24% in 2024.
• Over 5 years, Treasury Shares stood at $15.2 billion in 2022, then advanced by 4.94% to $16.0 billion in 2023, then increased by 5.4% to $16.8 billion in 2024, then advanced by 1.98% to $17.2 billion in 2025, then gained by 4.6% to $18.0 billion in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $18.0 billion in Q2 2026, $16.9 billion in Q1 2026, and $17.2 billion in Q4 2025.